Company: ENTXW
Filing Date: 2025-05-14
Form Type: PRE 14A
Source: 0001178913-25-001794
Chunk: 1

Company: Entera Bio Ltd.
Filing Date: 2025-05-14
Form: PRE 14A
Chunk 1
---
 Officer and a Director; |

| 3. | To ratify and approve the compensation terms, as described in the accompanying proxy statement, to Dr. Gregory Burshtein, our Chief of Research and Development; |

| 4. | To ratify and approve the compensation terms, as described in the accompanying proxy statement, to Ms. Dana Yaacov-Garbeli, our Chief Financial Officer; |

| 5. | To ratify and approve the amended and restated compensation policy for the directors and officers of the Company; |

| 6. | To consider and vote on the advisory resolution regarding the compensation of our named executive officers; |

| 8. | To consider any other business as may properly come before the Annual Meeting and any adjournment or postponement of the Annual Meeting. |

In addition, our shareholders will be requested to consider at the Annual Meeting our audited consolidated financial statements for the fiscal year ended December 31, 2024. No vote is required regarding this item. The foregoing proposals are described more fully in the enclosed proxy statement, which we urge you to read in its entirety. Only holders of record of our ordinary shares, par value NIS 0.0000769 per share (the “Ordinary Shares”), at the close of business on Tuesday, May 20, 2025, are entitled to notice of and to attend and vote at the Annual Meeting and any adjournments thereof. The vote required to approve the resolutions to be presented is set forth in each proposal brought for shareholders’ approval in the accompanying proxy statement. Whether or not you expect to be present at the Annual Meeting, please vote using the Internet, or by mail, in each case by following the instructions in our proxy statement. Shareholders who execute a proxy may nevertheless attend the Annual Meeting, revoke their proxy and vote their shares in person. Shareholders of record, who do not expect to attend the Annual Meeting in person, are kindly requested to mark, date, sign and mail the enclosed proxy card in the accompanying pre-addressed, postage-paid envelope as promptly as possible to our address below, c/o Dana Yaacov-Garbeli, our Chief Financial Officer. You may also vote your shares through the internet by going to www.voteproxy.comand following the on-screen instructions or scanning the QR code, located on the proxy card, with your smartphone. Please have your proxy card available when you access the webpage. Internet voting is available until 11:59 p.m